Our study was the first to pay close attention to exploring the association of plasma irisin with baseline characteristics in AS patients and evaluating the implication of baseline plasma irisin levels on post-TAVI clinical outcomes of AS patients. The gene discussed is FNDC5; the disease is aortic stenosis.